COVID-19 related acute respiratory distress syndrome: Pathological, radiological and clinical concordance | Zendy

Fatma Yıldırım | Zendy; Pınar Yıldız Gülhan | Zendy; Meltem Şimşek | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

COVID-19 related acute respiratory distress syndrome: Pathological, radiological and clinical concordance

Author(s) -

Fatma Yıldırım,

Pınar Yıldız Gülhan,

Meltem Şimşek

Publication year - 2021

Publication title -

tuberkuloz ve toraks

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.157

H-Index - 18

ISSN - 0494-1373

DOI - 10.5578/tt.20219708

Subject(s) - ards , medicine , concordance , pneumonia , diffuse alveolar damage , acute respiratory distress , radiological weapon , pathological , severe acute respiratory syndrome , covid-19 , intensive care medicine , respiratory disease , coronavirus , disease , pathology , lung , infectious disease (medical specialty) , surgery

Severe coronavirus 2019 disease (COVID-19) represents viral pneumonia from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection leading to acute respiratory distress syndrome (ARDS). However, when ARDS occurs as part of COVID-19, it has different features. The strategy of breathing support is very important in treating COVID-19 related ARDS (CARDS). Though it meets the CARDS Berlin definition, COVID-19 pneumonia is a specific disease with different phenotypes. Recently, it has been suggested that CARDS has two phenotypes, type L (Type 1 or non-ARDS) and type H (Type 2, ARDS), and these phenotypes respond differently to respiratory support treatments. In this review, after mentioning the pathophysiology and radiological relationship of CARDS, the definition and treatment approaches of two different forms of CARDS were discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research